Topical peptides are useful for certain applications (GHK-Cu copper peptide has reasonable evidence for topical activity), but for the major therapeutic peptides growth hormone secretagogues, BPC-157, Epithalon systemic delivery is required to produce the effects seen in the research literature
Click to read the study in JAMA Oncology In-Depth [retrospective cohort]: This retrospective cohort study was executed using the TriNetX network and included de-identified data from 1,221, 218 antidiabetic-nave and CRC-negative patients who were provided medical treatment for T2DM between 2005-2019
Disclaimer: Levocarnitine is a prescription treatment for carnitine deficiency
The report notes the presence of counterfeit Ozempic, the use of non-FDA-approved ingredients such as retatrutide or cagrilintide, and products bypassing regulations by being labeled as not for human consumption. As of July 2024 the most recently issued report the FDA had received over 1,000 reports of adverse events related to compounded semaglutide and compounded tirzepatide
To view a copy of this licence, visit About this article Cite this article Gjlberg, T.T., Mester, S., Calamera, G